Immunohistochemical characteristics of brain metastases and corresponding primary lung cancer

被引:1
作者
Marinova, Dora Marinova [1 ,2 ]
Mekov, Evgeni Vitkov [1 ,2 ]
Dimitrova, Denitsa Gosheva [1 ,2 ]
Titorenkov, Plamen Todorov [3 ]
Mihailov, Miroslav Martinov [1 ,2 ]
Nachev, Sevdalin Slavov [4 ]
Youroukova, Vania Milosheva [1 ,2 ]
Kostadinov, Dimitar Temelkov [1 ,5 ]
Slavova, Yanina Georgieva [1 ,6 ]
机构
[1] Med Univ, Clin Ctr Lung Dis, Sofia, Bulgaria
[2] Univ Hosp Pulm Dis St Sofia, Dept Pneumonol, Sofia, Bulgaria
[3] Sofia Univ, Mil Med Acad, Fac Med, Sofia, Bulgaria
[4] Univ Hosp St Ivan Rilski, Dept Pathol, Sofia, Bulgaria
[5] Univ Hosp Pulm Dis St Sofia, Dept Bronchol, Sofia, Bulgaria
[6] Univ Hosp Pulm Dis St Sofia, Dept Pathol, Sofia, Bulgaria
来源
JOURNAL OF BUON | 2019年 / 24卷 / 04期
关键词
brain metastases; immunohistochemistry; lung cancer; CELL CARCINOMA; SURVIVAL; PATTERN;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To study brain metastases (BM) and their corresponding primary lung cancers (LCs). Methods: Surgically resected BMs and their corresponding primary LCs from 30 patients (25 men, 83%, age 55 +/- 9 years) were studied: 21 adenocarcinomas (ACs), 5 squamous cell carcinomas (SCCs), 4 small cell lung carcinomas (SCLCs). The histological subtype, immunohistochemical expression of TTF1, p63, Ki67 (proliferative activity), CD31, number of intratumoral microvessels, (NIM) and survival were evaluated. Results: There was a different histological structure in 47% of the cases of ACs of the lung in comparison with the corresponding metastasis, but none in SCC and SCLC. TTF-1 was expressed in a greater number of ACs (n=20; 95%), with lower mean expression levels, while the corresponding BM expressed the marker less frequently (n=16; 76%) with higher mean expression values (p=0.011). P63 was expressed in all SCCs (p=0.68). Cytokeratin 7 was expressed equally in all ACs. Ki-67 proliferative index (PI) was higher in SCLC than in AC (p=0.008), in SCLC BM than in AC BM (p<0.001), and in SCLC BM than in SCC BM (p=0.008). The Ki-67 PI in BM was higher than in AC (p=0.003), SCC (p=0.048), but without difference in SCLC (p=0.141). CD31 NIM was higher in AC than in SCLC (p=0.003), in SCC than in SCLC (p=0.009), while no difference between AC and SCC was found (p=0.467). There were no differences between LC/BM in the NIM. Survival after surgery for LC was significantly longer in AC than in SCLC (p=0.017). SCLC histology and Ki67>18% were established as negative prognostic factors after surgery for LC. Such factors were not found after surgery for BM. Conclusion: There are differences between primary LC and corresponding BM - in histology, immunohistochemical expression and proliferative activity, but there are no significant differences in vascularization. SCLC histology and Ki67>8% may represent negative prognostic factors after surgery for LC with BM.
引用
收藏
页码:1626 / 1637
页数:12
相关论文
共 50 条
[21]   Genetic profiles of oligometastatic non-small-cell lung cancer and corresponding brain metastases [J].
Werner, Raphael S. ;
Rechsteiner, Markus ;
Moch, Holger ;
Curioni-Fontecedro, Alessandra ;
Weller, Michael ;
Weiss, Tobias ;
Regli, Luca ;
Le Rhun, Emilie ;
Mairinger, Fabian ;
Opitz, Isabelle ;
Soltermann, Alex .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2024, 65 (06)
[22]   MGMT promoter methylation status in brain metastases from colorectal cancer and corresponding primary tumors [J].
De Maglio, Giovanna ;
Casagrande, Mariaelena ;
Guardascione, Michela ;
Fontanella, Caterina ;
Lutrino, Stefania Eufemia ;
Rihawi, Karim ;
Pisa, Federica Edith ;
Tuniz, Francesco ;
Fasola, Gianpiero ;
Pizzolitto, Stefano ;
Aprile, Giuseppe .
FUTURE ONCOLOGY, 2015, 11 (08) :1201-1209
[23]   HER-2 Expression in Brain Metastases from Colorectal Cancer and Corresponding Primary Tumors: A Case Cohort Series [J].
Aprile, Giuseppe ;
De Maglio, Giovanna ;
Menis, Jessica ;
Casagrande, Mariaelena ;
Tuniz, Francesco ;
Pisa, Federica Edith ;
Fontanella, Caterina ;
Skrap, Miran ;
Beltrami, Carlo Alberto ;
Fasola, Gianpiero ;
Pizzolitto, Stefano .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (02) :2370-2387
[24]   Amplification and overexpression of CMET is a common event in brain metastases of non-small cell lung cancer [J].
Preusser, Matthias ;
Streubel, Berthold ;
Berghoff, Anna S. ;
Hainfellner, Johannes A. ;
von Deimling, Andreas ;
Widhalm, Georg ;
Dieckmann, Karin ;
Woehrer, Adelheid ;
Hackl, Monika ;
Zielinski, Christoph ;
Birner, Peter .
HISTOPATHOLOGY, 2014, 65 (05) :684-692
[25]   Lung cancer: atypical brain metastases mimicking neurocysticercosis [J].
Mota, Patricia Caetano ;
Reis, Carina ;
Pires, Nuno Filipe ;
Sousa, Graca ;
Chamadoira, Clara ;
Guimaraes, Marcos ;
Castro, Ligia ;
Marques, Margarida ;
Gomes, Isabel .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2011, 16 (06) :746-750
[26]   Attributes of brain metastases from breast and lung cancer [J].
Kyle Hengel ;
Gurinder Sidhu ;
Jai Choi ;
Jeremy Weedon ;
Emmanuel Nwokedi ;
Constantine A. Axiotis ;
Xianyuan Song ;
Albert S. Braverman .
International Journal of Clinical Oncology, 2013, 18 :396-401
[27]   The interaction between lung cancer metastases to the brain and their surroundings [J].
Tabaka, J ;
Nowacki, P ;
Pankowski, J .
FOLIA NEUROPATHOLOGICA, 2006, 44 (01) :42-49
[28]   Medical management of brain metastases from lung cancer [J].
Yamanaka, Ryuya .
ONCOLOGY REPORTS, 2009, 22 (06) :1269-1276
[29]   Treatment of brain metastases from lung cancer: chemotherapy [J].
Schuette, W .
LUNG CANCER, 2004, 45 :S253-S257
[30]   Attributes of brain metastases from breast and lung cancer [J].
Hengel, Kyle ;
Sidhu, Gurinder ;
Choi, Jai ;
Weedon, Jeremy ;
Nwokedi, Emmanuel ;
Axiotis, Constantine A. ;
Song, Xianyuan ;
Braverman, Albert S. .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (03) :396-401